Is the U.S. Ready for Value-based Pricing of Drugs?
May 18, 2016•25 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The federal government’s move to switch to value-based pricing of drugs for one category of public health plans could potentially have far-reaching effects say experts.
Hosted on Acast. See acast.com/privacy for more information.
For the best experience, listen in Metacast app for iOS or Android